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Abstract—This study pro jects prosthetic- and assistive-device 
costs for veterans with limb loss from Vietnam and injured ser-
vicemembers returning from Operation Iraqi Freedom (OIF) and 
Operation Enduring Freedom (OEF) to i nform the Department 
of Veterans Affairs (VA) for these veterans’  future care. The 
2005 Medicare prosthetic device component prices were applied 
to current prosthetic  and  assistive-device  use obtained from 
a national surv ey o f 581 v eterans and servicemem bers wit h 
major traumatic amputations. Projections were made for 5-year, 
10-year, 20-year, and lifetime costs based on eight Markov mod-
els. Average 5-year projected costs for prosth etic and assistive-
device replacement for the Vietnam group are lower than for the 
OIF/OEF cohort due in part to use of fewer and less technologi-
cally advanced prosthetic devices and higher frequency of pros-
thetic abandonment. By limb-loss level, for the Vietnam group 
and OIF/O EF cohort ,  5-year pr ojected uni lateral upp er li mb 
average costs are  $31,129 and $117,440, unilateral lower  limb 
costs are  $82,251 and  $228,665, and multiple limb co sts are 
$130,890 and $453,696, respectively. These figures provide the 
VA with a funding estimate for technologically advanced pros-
thetic and assistive devices within  the fram ework of on going 
rehabilitation fo r vet erans with traumatic limb loss from the 
Vietnam and OIF/OEF conflicts.
Key words:  amputation, assisti ve device, cost proj ection, 
costs, limb loss, Markov model,  OIF/OEF, prosthetics, reha-
bilitation, Vietnam.
INTRODUCTION
The Department of Defense (DOD) Rehabilitation 
Directive aims to return se rvicemembers with  limb loss 
from Operation Iraqi  Freedom  (OIF) and Operation 
Enduring Freedom (OEF) to preinjury function and pro-
vide  the option of returnin g  servicemembers to Active 
Duty. As of Ju ne 2008, the DOD Amputee  Patient Care 
Programs at Walter Reed Army Medical  Center (Wash-
ington, DC), Brooke Army Medical Center (San Antonio, 
Texas), and Naval Medical Center (San Diego, California) 
have provided nearly 1,000 servicemembers with state-of-
the-art comprehensive  rehabilitation  care, including the 
provision of advanced technology, prosthetic and assistive 
Abbreviations:  ASR =  age-sex-ra ce-adju sted (death  rates), 
DOD = Department of Defense, DSS = Decision Support Sys-
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devices, and training to restore function to the extent pos-
sible [1].* Servicemembers who  benefit from these ser -
vices continue to transition to the Department of Veterans 
Affairs (V A), where the pros thetic-device distribution 
practice allows all veterans with limb loss to receive pros-
thetic devices  ac cording to  their  functional level  if 
deemed medically appropriate by their managing physi-
cian [2–3].
In 2008, the VA Prosthetic and Sensory Aids Service 
was the largest provider of durable medical equipment in 
the world, serving more than 1.9 million veterans with an 
annual budget of $1.4 billion. † In 2008, VA laboratories 
and co ntract pro sthetic labo ratories mad e  or repaired 
prostheses for approximately 12,059 veterans at a cost of 
$74,656,247, accounting for 5  percent of  the Prosthetic 
and Sensory Aids Service budget. Veterans and service-
members with  major combat-associated limb  loss are a 
part of the app roximately 40,000 individuals with limb 
loss served by the VA Prosthetics and Sensory Aids Ser-
vice. Veterans are not  responsible for prosthetic  device 
costs and are free to choose either a private contract pros-
thetist or a VA prosthetist. Sixty-one VA medical centers 
have nationally accredited prosthetics  laboratories, and 
the VA has contracts with more than 600 small local busi-
nesses that meet the same  accreditation standards [4–5]. 
An estimated 95  percent of  all prosthese s provided 
through the VA are fitted through this network of private 
contractors.† The VA reimburses vendors based on nego-
tiated contracts at approximately 5 to 10 percent less than 
Medicare rates.†
Previous  literature evaluati ng  costs in patient s  with 
limb loss focused on healthcare costs of different surgical 
procedures (such  as  immediate or delayed  amputations 
[6], surgical reconstruction, and amputation [7–8]) or costs 
of different types of prosth etic devices [9–10]. No  pub-
lished research ha s projected  lifetime costs  incorporating 
the diverse combinations of pr osthetic devices in current 
use today. This study on  cost  is part of a  larger research 
project to provid e VA clinicians and  policy makers with 
information on recent changes  in prosthetic- device utili-
zation patterns, cost comparisons, and exp ert recommen-
dations [2]. The purposes of this study are (1) to estimate 
costs of dif ferent types of  prosthetic devices based  on 
Medicare costs an d (2) to  then project future prosthetic-
device costs based on reported prostheses use in two con-
flict-era cohorts (Vietnam and OIF/OEF).
METHODS
National Survey
Participants in the national Survey for Prosthetic Use
(Appendix 1, available online only) are veterans from 
the Vietnam conflict (1961–1973) and servicemembers 
from the OIF/OEF conflicts (2000–2008) with at least 
one  major traumatic amputatio n (exclu ding  digit-only 
loss) occurring in the combat theater. 
Survey Participants
All servicemembers with major limb loss (excluding 
digit-only) from OIF/OEF were invited to participate. We 
invited all Vietnam veterans with unilateral  upper-limb 
loss, all with multiple limb loss, and a random sample of 
those with unilateral lower-limb loss to participate so we 
could obtain comparable numbers from both eras. Survey 
participants include 298 from the Vietnam conflict (65% 
response rate) and 283 from the OIF/OEF conflicts (59% 
response rate). Participants were surveyed using one of 
three methods (mail , telephone interview, or W eb site) 
during 2007 and 2008.
Expert Panel
A panel of 2 5 ex perts in  limb loss and prosthetic-
device care, which consisted of researchers from VA, DOD, 
academia, and private-practice and veterans with limb loss 
from Vietnam  and OIF/OEF co nflicts (further describ ed 
elsewhere [ 2]) a dvised  the  project te am.  The pa nel  pro-
vided input on prostheti c and rehabilitation issues, model 
parameters, and data analysis and interpretation in multiple 
telephone conferences and a 3-day meeting.
*Scoville, Charles R.  (Amputee Pa tient Care Servic e, Inte grated 
Department of Orthopaedics an d  Rehabilitation, National Nav al 
Medical Center, Walter  Reed Ar my Medical Center ,  Washington, 
DC). Email to: Gayle E. Reiber (Program Analyst, Department  of 
Prosthetic and Sensory Aids, VA Puget Sound Health Care System, 
Seattle, W A). E mail on a mputee  monthly statisti cs for perso ns 
treated in all Army facilities. 2009 Jun 1.
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Cost Estimation Overview
Our approach to projecting prosthetic and  assistive 
device costs was based on Medicare 2005 costs applied 
to prosthetic-device use patterns obtained from a national 
survey ( Appendix 1 , available  online only).  Figure 1
shows that the overall process of projecting costs began 
with collecting information  from 298 veterans from the 
Vietnam conflict and 283 servicemembers from the OIF/
OEF conflict with major limb loss (Step 1). In Step 2, we 
developed a cost matrix to determine the a verage cost of 
the prosthetic-device system. The costs va ry by type of 
prosthetic device, level of limb loss, and functional capa-
bility. In Step 3, by applying costs estimated by the cost 
matrix, we created a cost file to estimate the total cost for 
each survey participant based on current prosthe tic- and 
assistive-device use reported in the survey. In Step 4, we 
developed eight Markov models specifying four types of 
limb loss (unilateral lower ,  unilateral upper , bilateral 
upper, and other multiple limb loss) for the two conflicts 
(Vietnam and OIF/OEF) to model the data. In Step 5, the 
results for 5-year, 10-year, 20-year, and lifetime projected 
prosthetic- and as sistive-device  costs were   calculated. 
Detailed explanations of each step of the model follow.
Step 1: National Survey Inputs
Veterans  and servicemembers participatin g i n th e 
national survey (Appendix 1, available online only) pro-
vided information on their ag e, military conflict, and the 
level of limb loss for each injured limb.
Prosthetic Device Types
The survey provided pictures and brief descriptions 
of groups of pro sthetic device sy stems and queried ser-
vicemembers on the  types  and quantities of  prosthetic 
devices ever received. Currently used prosthetic device 
data included type, number, and frequency of use. Survey 
participants also indicated the frequency of us e for each 
prosthetic device type: daily, weekly, monthly, or one to 
two times per yea r. Replacement frequencies were col-
lected for each type of prosthetic device.
Current us e of  assistive de vices w as  also re ported. 
Assistive devices included  manual and electronic wh eel-
chairs; w alking a ids (c anes, crutc hes, w alkers);  and fo r 
Figure 1.
Steps involved in cost projections for Vietnam and Operation Iraqi Freedom/Operation Enduring Freedom groups with major traumatic limb loss.390
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those with upp er-limb loss,  upper -limb attachmen ts to 
facilitate activities of daily living (including car modifica-
tions).
Level of Limb Loss
Each individual’s most  proximal limb-loss level was 
used as his or her level of limb loss for the Mark ov mod-
els. Limb loss was grouped as unilateral lower, unilateral 
upper, bilateral upp er, and multip le limb loss. Th e levels 
of lower-limb loss were categorized as partial  foot, ankle 
disarticulation, transtibial, knee disarticulation, transfemo-
ral, hip disarticulation, and  transpelvic (none reported in 
survey). Upper-limb loss  was grouped into seven levels: 
partial hand, wrist disarticulation, transradial, elbow disar-
ticulation, transhum eral,  shoulder disarticu lation,  and 
forequarter (none reported in  survey). Detailed descrip-
tions of survey participants with unilateral lower-limb loss 
[11], uni lateral up per-limb lo ss  [12],  and  multiple l imb 
loss [13] and survey participants not using prosthetic and 
assistive devices [14] are described in other articles in this 
issue.
Functional Level
Currently,  the  most w idely re cognized system for 
assessing functional capability for those with lower-limb 
loss is the Medicare Func tional Classif ication Level 
(MFCL) [15–16]. MFCLs are t ypically assigned by the 
physician and rehabilitation team and are descriptors of a 
patient’s potent ial  functional capability.  Most patients, 
including many  veterans a nd  servicemembers, are  not 
aware of the MFCL numeric value assigned by their cur-
rent prosthetics provider. To facilitate the survey partici-
pants’  self-assessment of their curre nt lower -limb 
functional capability level, project experts  modified the 
MFCL tool and developed a hierarchy of increasing func-
tion in daily tasks and activities from Level 1 to Level 7, 
as shown in Table 1.
Step 2: Cost Matrix
The objective of the cost matrix was to estimate the 
cost of typical prosthe tic device systems used by survey 
participants. We found that  this cost depe nds on  three 
characteristics: the type of prosthetic device (by varying 
degrees of technology), the level of limb  loss, and the 
functional capability . For  lower-limb loss,  more than 
400 unique pros thetic-device-type cost scenarios exist, 
predicated on  six major  prosthetic device types, seven 
limb-loss levels, and sev en functional capability  levels. 
The first important characteris tic influencing cost  is the 
type of prosthetic device system. Therefore, the first step 
was to categorize prosthetic devices within a group shar-
ing a similar level of technology. Given the wide range of 
prosthetic devices  and s uppliers,  it wa s imprac tical to 
attempt specific identification of each component or sup-
plier for a prosthetic device  for each survey participant. 
In lieu of specific  device identification and costing, the 
survey grouped prosthetic devices into categories appro-
priate to prosthetic comp onent technology . These six 
“prosthetic devic e types”   for lower -limb loss devices 
included microprocessor, hybrid, mechanical, sports/spe-
cialty, waterproof, and cosmetic.
The second important cost charac teristic is the level 
of limb loss.  In our survey, 87 percent of participants 
with unilateral lower-limb loss were at the transtibial or 
transfemoral leve l. The refore,  for  lower-limb los s,  we 
focused  our  estimates on  these two limb-loss levels. 
Costs of lower limb prosthetic device systems were esti-
mated for each level of limb loss within functional levels 
and confirmed by the expert pane l. For  example,  for 
functional levels 4 to 7, microprocessor prosthetic device 
systems had compiled costs for the following  levels of 
lower-limb loss: partial foot ($14,187), ankle disarticula-
tion  ($16,356), transtib ial ($1 6,690), k nee ($ 45,563), 
transfemoral ($45 ,563),  hip ($4 5,633), an d transpelvi c 
disarticulation ($49,208).
Table 1.
Functional capability levels of those with lower-limb loss in Survey of 
Prosthetic Use (Appendix 1, available online only).
Functional
Level
Prosthetic Use Description
 7 High-impact activities: Usually jog or run 
and do high-impact sports (e.g., skiing, 
mountain climbing).
 6 Low-impact activities: Can run but usually do 
low-impact activities (e.g., swimming, golf-
ing, hiking).
 5 Can walk with varying speeds (slow to 
fast) over uneven surfaces and barriers.
 4 Community walker (walk around community 
over short barriers; can walk on uneven 
surfaces).
 3 Household walker (walk around the house 
on even surfaces only).
 2 Do not need help to transfer but cannot 
walk.
 1 Need help to transfer; cannot walk.391
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The third cost characteristic is the functional capability 
of the person with limb loss and the types of activities done 
in daily life. Functional capability plays a significant role 
in the cost of the components u sed to create  a prosthetic 
device system. In  addition, for those whose daily  living 
activities include high-impact occupational or recreational 
activities, we found that not only were more devices used 
but also a wider diversity of prosthetic devices was in use.
The last step in developing  the cost  matrix was to 
estimate total costs ba sed on the  three cost characteris-
tics. The costs for transtibial and transfemoral levels were 
determined by assigning Me dicare L-codes a ppropriate 
for prosthetic device type, limb-loss level, and functional 
level. The c ost for each L-code was assigned using  the 
median Medicare cost for the 50 states and the District of 
Columbia. Our cost  reference wa s the  “Fee  Schedule 
Update for 2005 for Durabl e Medical Equipment, Pros -
thetics, Orthotics, and Supplies (DMEPOS)” for nonin -
stitutional providers [17].
Table 2  provides the specific L-codes, descriptions, 
and 2 005 Medicare costs for ty pical co mponents of a 
microprocessor knee at the transfemoral level to illustrate 
the process. The total  cost of a prosthetic device system 
is  $45,563.17. The c ost matrix for transfemora l-level 
limb loss is shown in Table 3: the compiled cost is at the 
junction of the  participant’s functional capability (rows) 
and the type of prosthetic device (columns). We devel-
oped a cost matrix  for each level  of limb loss (dat a not 
shown). The c ost for the prosthe tic device described in 
Table 2 is found in the microprocessor column in Table 3
for functional levels  4 to  7. No costs are  assigned for 
Table 2. 
L-codes and Medicare 2005 costs for transfemoral microprocessor knee.
L-Code Healthcare Common Procedure Coding System* Quantity
2005 Median ($)
Each Total
L5321 Def mold socket SACH ft endo 1 2,881.74 2,881.74
L5981 Flex-walk sys low ext prosth 1 2,590.78 2,590.78
L5986 Multi-axial rotation unit 1 536.47 536.47
L5930 Hi activity frame 1 2,729.48 2,729.48
L5828 SNS 1 2,376.90 2,376.90
L5850 Ext assist 1 102.59 102.59
L5925 Man lock 1 349.76 349.76
L5856 MPC swing & stance 1 19,264.21 19,264.21
L5848 Stance extension control 1 863.12 863.12
L7368 Battery charger 1 405.09 405.09
L5845 Stance flexion 1 1,438.67 1,438.67
L5984 Endoskeletal axial rotation 1 518.65 518.65
L5950 Endo ultra-light material 1 670.29 670.29
L5920 Endo alignable sy 1 425.51 425.51
L5624 Test socket  2 322.04 644.08
L5637 Total contact 1 266.74 266.74
L5631 Acrylic socket 1 352.37 352.37
L5649 Ischial containment 1 1,663.03 1,663.03
L5651 Flex inner socket ext fra 1 963.10 963.10
L5679 Socket insert w/o lock mech 2 500.61 1,001.22
L5698 Silesian belt 1 96.24 96.24
L5781 Lower limb pros vacuum pump 1 3,211.60 3,211.60
L5705 Custom shape cover 1 818.55 818.55
L5964 Flex cover system 1 848.66 848.66
L8430 Prosthetic sock multi ply 12 19.51 234.12
L8480 Pros sock single ply 12 7.38 88.56
L8410 Sheath 12 18.47 221.64
Total — — — 45,563.17
*Based on American Medical Associations’ Current Procedural Terminology.392
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microprocessor devices at the transfemoral level at lower 
functional levels, because these devices are not used for 
nonambulatory or house hold walkers (according  to the 
opinions of the expert panel).
Costs of upp er-limb prosthetics were  estimated by 
grouping upper-limb prosthetic devices by device types 
and level of limb loss. Unlik e the lower-limb prosthetic 
cost matrix, functional capability was not considered for 
upper-limb prosthetic devices because no equivalent sys-
tem, such as the MFCL used for lower limbs, is in current 
use for upper-limb loss. Survey participants with upper-
limb loss also had fewer prosthetic device options than 
those with lower li mb loss. T wenty-eight potential cost 
scenarios were evaluated for upper -limb us e ba sed on 
four major prosthetic device types (myoelectric, hybrid, 
mechanical, and cos metic) and the  seven limb-loss lev -
els. Final survey data indicated that 71 percent of survey 
participants with upper-limb loss were either at the trans-
radial or transhumeral level; thus, prosthetic device  cost 
development focuse d primarily on these two limb-loss 
levels. The prosthetic device costs for the remaining five 
levels of limb loss were derived by decreasing or increas-
ing the transradial or tran shumeral value s as deemed 
appropriate by the e xpert panel. For  example, myoelec-
tric prosthetic devices had compiled costs for the follow-
ing levels  of upper limb  loss: p artial ha nd ($1 8,703), 
wrist ($19,922), transradial ($20,329), elbow (not appli-
cable), transhumeral ($59,664), shoulder ($61,655), and 
forequarter disarticulation ($62,271).
Step 3: Current Cost File
For each survey participant, we accumulated the esti-
mated costs over time for all devices used. This total cost 
is base d  on the number of past  and  current  prosthetic 
devices reported in the surve y and on the application of 
costs from  the cost  matrix (based on prosthetic device 
type, level of limb  loss, and functional capabilit y). For 
modeling purposes, total costs were stratified by combat 
cohorts (Vietnam and OIF/OEF) and the following limb-
loss groups: unilateral lower , unilateral upper, bilateral 
upper, and multiple limb loss.
Step 4: Markov Models for Cost Analysis
Markov models, commonly  used in chronic dis ease 
research, were used to make cost projec tions over four 
different time horizons associated with limb loss: 5 years, 
10 years, 20 yea rs, and lif etime (up to 100 ye ars) [18–
22]. Our cost analysis included only the projected costs 
of prosthetic devices and a ssistive devices. The model 
estimates did not include costs for repair and increases in 
costs due to future tec hnologies. Therefore, thes e cost 
estimates are conservative.
In defining our model, we used the set of principles for 
cost-effectiveness analysis developed by Weinstein et al. 
Table 3.
Cost matrix for costs of prosthetic device types by functional level for transfemoral limb loss based on Medicare 2005 costs in 2005 dollars.
Functional Level
No Prosthesis
Use
Micro-
Processor
Hybrid-
Mechanical/
Electronic
Traditional/
Mechanical
Specialty/
Running
Water-
proof
Passive/
Cosmetic
1: Need help to transfer; cannot walk. N/A N/A N/A N/A N/A N/A N/A
2: Do not need help to transfer but
cannot walk.
N/A N/A N/A 6,409 22,906 19,649 10,967
3: Household walker (walk around
house on even surfaces only).
N/A N/A N/A 9,360 22,906 19,649 10,967
4: Community walker (walk around com-
munity over short barriers; can walk on 
uneven surfaces).
N/A 45,563 35,196 15,796 22,906 19,649 10,967
5: Can walk with varying speeds (slow to 
fast) over uneven surfaces and barriers.
N/A 45,563 35,196 18,713 22,906 19,649 10,967
6: Low-impact activities: Can run but usu-
ally do low-impact activities (e.g., 
swimming, golfing, hiking).
N/A 45,563 35,196 21,815 22,906 19,649 10,967
7: High-impact activities: Usually jog or 
run and do high-impact sports (e.g., ski-
ing, jogging, mountain climbing).
N/A 45,563 35,196 25,196 22,906 19,649 10,967
N/A = not applicable.393
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[23]. Our Markov models consist of four basic components: 
(1) a basic model structu re known as the cy cle tree; 
(2) functional states (the fu nctional level s) with corre -
sponding prosthetic cost distributions; (3) transition proba-
bilities, modeling the likelihoo d of a survey participant 
moving from one functional state to another over time; and 
(4) prosthetic and assistive  device assumptions. Method-
ological details of each component of the models follow.
Basic Model Structure
Data on current prosthetic device use were available 
from survey participants. Th e expert pa nel then recom -
mended the basic structure and transition probabilities for 
our models given the absence of prior published research 
in this area. We began with a 1-year cycle length to allow 
for rap id  changes in  p rosthetic  device u se  during  the 
5 years following the first postamputation year. After the 
fifth year, the probabilities of transitioning to other func-
tional levels were decreased to reflect the relative stabil-
ity in prosthetic device use during later years.
Functional States
The functional s tates from  Table 1  are se ven levels 
of increasing funct ional ability for daily  physical tasks 
and ac tivities.  The  expert panel a greed  that ea ch year 
subjects would likely remain in the same functional state, 
or if they moved, it would be either up or down one func-
tional level, not two  or more levels. In Figures 2 and 3, 
death is included as a component of the Markov models, 
since these models simulate the life experience of veter-
ans and servicemembers with limb loss.
Transition Probabilities
The expert  panel advised  on transition  probabilities 
(the probability of  moving fr om one  functional level  to 
another) for the Mark ov model.  In general, the  consensus 
from the expert panel defined  general trends  of changing 
from one functional level to  another over 1 year  but was 
unable to defin e transitions for every year  in the model. 
Because of a  lack of evid ence regarding transition proba-
bilities for  those wi th limb loss,  we accounted for  this 
uncertainty in the models. Specifically, we treated transition 
probabilities, not as fixed, known quantities, but as values 
that change over the simulated time in the model through 
the  use of probability dist ributions. The model out put 
reflects this variability because each year in the simulation, 
a transition probability is drawn at random from the speci-
fied distribution. Th e year-to-year variability captures  the 
range of prosthetic dev ice use and function in our popula-
tion reported in the national survey.
We used the Dirichlet distribution  [24] to model  the 
transition from a given fun ctional  level to one level 
Figure 2.
Markov model for unilateral lower limb and multiple limbs for Opera-
tion Iraqi Freedom/Operation Enduring Freedom (OIF/OEF)  group. 
ASR = age-sex-race-adjusted death rates.
Figure 3.
Markov model for unilateral upper limb and bilateral upper limbs for 
Operation Iraqi  Freedom/Operation Enduring Freedom (OIF/OEF) 
group. ASR = age-sex-race-adjusted death rates.394
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higher, one level lower , or re maining at the same level. 
Based on  expert panel discussions, a  baseline Dirichlet 
distribution was used for the  first 5 years  of transitions 
starting 1 year  postamputation and   a second Dirichlet 
distribution was used for tran sitions after 5 years. This 
general rule was  applied to all individuals, regardless of 
individual activity level. The baseline distribution, based 
on expert panel consensus, has probabilities of transition 
at 0.1, 0.1, and 0.8. These indicate that, in any given year, 
the probability of moving to a  functional state one level 
higher is 0.1, the probability  of moving one level lower 
than  the curren t level is  0.1,  and the probability of 
remaining in the current functional state is 0.8. Similarly, 
for transitions after 5 years, the expected transition proba-
bilities change to 0.05, 0.05, and 0.9,  for moving to a 
higher level, moving to a lower level, or staying the same, 
respectively. Based on their experience, the e xpert panel 
indicated that fewer transiti ons occur  after 5 years, and 
those  that  do are primarily re lated to weight  gain or 
weight loss; therefore, the transition probabilities used in 
the 5-year period were also used for the estimates for the 
10-year, 20-year, and lifetime  periods. The mean values 
for these transitional probabilities provided by the expert 
panel were used as the mean value for new distributions 
as the model was cycled.
When a simulated person in the model dies, he or she 
transitions to the  death  state. W e obtained transiti on 
probabilities to the death st ate as age-sex-race-adjusted 
(ASR) death rates from publis hed vital statistics. S epa-
rate death rates w ere used  for the OIF/OEF group  [25] 
and the Vietnam group [26] because of the groups’ differ-
ent age-dependent mortality probability. These probabili-
ties a re  given  in  1-year increments for the  OIF/OEF 
group and in 5-y ear increments for the Vietnam group. 
Linear interpolation was used to determine intermediate 
yearly death rates for the Vietnam group. Both mortality 
tables showed yearly survival rates after the age of 100 to 
be zero; therefore, lifetime costs were modeled on a time 
horizon of 100 years.
The cycle tree  for OIF/OEF unilateral  lower- and 
multiple-limb groups  is shown in  Figure 2 . Similarly, 
Figure 3 shows the cycle tree for OIF/OEF unilateral and 
bilateral upper-limb groups. In each figure, the first node 
on the left represents a summ ary of the initial conditions 
of the model at 1 year po stamputation. The second col-
umn displays the functional levels from Table 1 . At each 
functional state, the model assigned costs for  each simu-
lated year and the transition  probability specifications 
associated with each option. Each branch from the func -
tional state  circle shows  the  transition to either death 
using mean ASR death rate or survival at a higher, lower, 
or the same level of function for another year. Each simu-
lated year is represented by  one cycle of th e model, tra-
versing the figure from left to right once. For example, to 
project 20-year cumulative average costs, the model simu-
lates a lar ge cohort of su rvey participants moving 
(cycling) through the tree 20 times. In the Markov model, 
functional-level costs were  randomly sampled from  the 
resulting distribution of costs. All costs within an activity 
level were equally likely to be drawn on each iteration of 
the cost simulation, accounting for the variability in costs.
To assess the robustness of  our transition probabili-
ties, we perf ormed a f ormal sensit ivity an alysis  [23]. 
Since no empirica l studies ar e available to  inform selec-
tion of t hese transition probabilities, we simul ated costs 
using a “worst case” Dirichlet distribution; that is, one in 
which all probabilities between 0 and 1 are equally likely. 
This simulation is achi eved by speci fying a  distribution 
with  all probabil ities set t o  0.33. Thus, the transition 
probabilities for each of the three  outcomes are equall y 
likely. Given the lack of data, we considered this approach 
analogous to that suggested by Briggs et al. [24].
Model Assumptions and Considerations
First, a key  Markov  model assumption is  that  the 
functional level to which a subject moves in a given year 
depends only on his or her functional level th e previous 
year, not on prior y ears. By defining a cycle leng th of 
1 year for our model, this assumption was warranted [19]. 
Second, the value of a dollar today  is not the same as  its 
future value. Discounting fu ture  cost projections to  a 
baseline time is important to assess the present value of all 
projected costs. Health economists agree that discounting 
is necessary, and the 3 percent discount rate, supported in 
the literature [23], was used to compute the present value 
of all cost projections relative to the year 2005. Third, we 
account for important asp ects of prosthetic device use in 
this simulation by including the number  of devices  used 
and types of prosthetic devices from th e reported data in 
the national survey. Fourth, cost variability was accounted 
for by sampling within the range of observed costs of our 
study participants. Fifth, the costs of repairs, service, and 
new prosthetic device technology are not included in the 
models. Sixth, the expert panel contributed to the model 
structure shown  in Figures 2 and  3 by setting baseline 
transitional probabilities for th e first year and for later 
years. Weinstein et al. indicate expert opinion is  a legiti-
mate met hod for  assessing  parameters, provided  either 395
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that these parameters are shown not to af fect the  results 
importantly or that a sensitivity  analysis is reported on 
these parameters with a clea r statement that results are 
conditional upon the subjective estimate(s) [23].
After specifying the structure of the model, the func-
tional states and  costs, and the prob abilities of moving 
between functional states, we used the model to simulate 
cost accrual over the various time horizons by simulating 
a group of survey participants moving through the model 
1,000 times  (at which time  all participants reached  the 
endpoint of death). In each cycle, a simulation of 1-year, 
functional-level cost distr ibutions and transition proba -
bilities was sampled from their corresponding databases. 
Each simulated participant th en traversed the cycle tree 
with the given probabilities and  costs to obtain costs for 
that simulated year. This was repeated for the number of 
years for the given time horizon (5, 10, 20, or lifetime). 
Lifetime costs were  obtained by repe atedly c ycling 
through the tree  until all participants of the simulation 
group died .  This resu lted  in 1,0 00 proj ected average 
costs, all different, because of the sampling of costs and 
the sampling of transition probabilities.
For the simulations, the proportion of the group ini -
tially in each functional level was estimated by the corre-
sponding proportion reported in our surv ey data. Since 
these proportions were obtained from a  sample of ser -
vicemembers, they vary from the true population propor-
tions. The Dirichlet distribution was used to allow for the 
sampling uncertainty in  these functional-level frequen -
cies, with marginal means corresponding to the frequen-
cies observed from the questionnaire.
Statistical Methods
Summary statistics, including  mean, standard devia -
tion, and quantiles were computed for the following cate-
gories: unilateral upper -limb  loss, unilateral lower -limb 
loss, bilateral upper -limb loss, and multiple limb loss in 
the Markov models. Markov models and simulations were 
conducted  using TreeAge Pro  2008 s oftware  (TreeAge 
Pro; Williamstown, Massachuse tts). Details on Markov 
models are prov ided in other articles on  modeling costs 
[27], practical aspects of modeling [28], and recent devel-
opments with technical and mathematical details [29–30].
We  used S tata 9 .2  (StataCorp; College  Station, 
Texas) for comparisons of prosthetic use. Statistical sig-
nificance was based on chi-square (categorical data) or 
Student t-test (continuous data). The level of significance 
was for a two-sided p < 0.05.
RESULTS
The projected costs are based on four limb-loss groups 
within each of the two  conflict groups (298  Vietnam and 
283 OI F/OEF  participants):  unilateral l ower-limb loss 
with 47 and 50 participants, respectively; unilateral lower-
limb loss, 178 an d 172, respectively; bilateral upper-limb 
loss, 6 and 7, respectively; and other types of multiple 
limb loss, 67 and 54, respectively. The average number of 
prosthetic devices in current  use differs between conflict 
groups. There were sign ificant  differences in prosthetic 
device use in the two conflict groups. Reiber et al. reported 
78 percent of the V ietnam cohort currently use prosthetic 
devices, while 90 percent of the OIF/OEF cohort  are cur-
rent users of prosthetic devices [2].  Table 4  shows that 
current prosthetic use by limb-loss  level was up to three -
fold higher in the OIF/OEF group than the Vietnam group, 
no matter which level of limb loss.
The Markov models’ cost projections across all time 
horizons for unilateral upper-limb groups are presented in 
Table 5 . The average 5-year projected cost is $31,129 for 
the Vietnam veteran group, in which only 70 percent cur-
rently use prostheses, and of  these, 78 percent are  tradi-
tional mec hanical devices. The O IF/OEF group with 
unilateral upper-limb loss use nearly twice as many pros-
theses as the Vietnam group. A higher proportion, 76 per-
cent, u se  prostheses (4 6% m yoelectric a nd  38% 
mechanical); thus, their aver age 5-year cost projection 
($117,440) is higher than that of the Vietnam group. Note 
that the maximum  simulated 20-year costs for the  Viet-
nam cohort exceed the maximum lifetime costs. This may 
occur when simulated data are based on sampling from a 
range of probabilities, and the lower costs in the lifetime 
follow-up populations are due to lower survival frequen -
cies and therefore fewer prosthetic devices are used.    
Table 6  shows cost projections  in those with  unilat-
eral lower-limb loss. Prostheses were used by 84 percent 
Table 4.
Average number of report ed currently used prosthetic devices by type  
of limb loss (mean ± standard deviation) for Vietnam and OIF/OEF sur-
vey participant groups.
Limb Loss Vietnam OIF/OEF
Unilateral Upper Limb 1.0 ± 0.8 1.8 ± 1.7*
Unilateral Lower Limb 1.2 ± 0.9 3.1 ± 2.5*
Bilateral Upper Limb 2.2 ± 3.0 4.7 ± 3.7
Other Multiple Limbs 1.8 ± 1.5 5.7 ± 4.9*
*p < 0.05 compared with Vietnam group.
OIF/OEF = Operation Iraqi Freedom/Operation Enduring Freedom.396
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of Vietnam veterans  compared with  94 percent in the 
OIF/OEF group. The OIF/OEF  group use 2.6-fold more 
devices than the Vietnam group. More of the OIF/OEF 
group use microprocessor devices (13%) than the Viet-
nam group (7%, p < 0.05). The average 5- and  10-year 
costs for Vietnam veterans were $82,251 and $167,848, 
respectively, compare d w ith $ 228,665 and  $4 73,951, 
respectively, for the OIF/OEF group.
Findings for veterans and servicemembers with bilat-
eral upper-limb loss appear in Table 7 . Only 50 percent 
of the V ietnam group (n = 6) use  prostheses compared 
with 86 percent in the OIF/OEF group (n = 7). The OIF/
OEF group use more than twice  the number of prosthe-
ses; thus, a wide dif ference in 5-year  average costs is  
observed: $90,065 compared with $333,445. More of the 
OIF/OEF group with bilatera l limb loss use myoelect ric 
devices (71%) than the Vietnam group (17%, p < 0.05).
Table 8  pres ents  results for veterans a nd se rvice-
members with other types of multiple limb loss. Prosthe-
ses  are  used by  70 perce nt of the  Vietnam  group a nd 
93 percent of  the OIF/OEF group. The OIF/OEF group 
uses over thre efold more prostheses   than the V ietnam 
group. More of the OIF/O EF group with multiple limb 
loss  use a dvanced  technology devic es (myoelectric or 
microprocessor) than the Vietnam group (51% and 14%, 
respectively, p = 0.01). Five-yea r average costs for the  
Vietnam group were $130,980 compared with $453,696 
for the OIF/OEF group.
The distributions in  Tables 5   to 8  show the vari -
ability in projected costs and the uncertainty in transition 
probability specification. As illustrated in the  tables, the 
standard deviation of costs steadily increase as the length 
of the projec ted time horizo n increases for both cohorts 
and all types of limb loss.
Lifetime costs for 298 me mbers of the V ietnam 
group varied by type of limb loss. The projected costs for 
the Vietnam veterans (Figure 4) show uni lateral upper-
limb  loss has the lowes t lifetime  estimated cost of 
Table 5.
Cost projections (in U.S. dollars) from Markov model: Unilateral upper-limb groups (n = 47 and 50 for Vietnam and OIF/OEF groups, respectively).
Variable
5 Yr 10 Yr 20 Yr Lifetime
Vietnam OIF/OEF Vietnam OIF/OEF Vietnam OIF/OEF Vietnam OIF/OEF
Mean 31,129 117,440 61,957 251,165 107,698 465,139 131,900 823,239
SD 24,340 42,625 30,745 59,545 38,610 77,415 38,287 88,742
Minimum 2,673 12,014 13,556 89,810 43,184 241,001 59,512 560,186
2.5% 8,039 46,677 26,187 148,558 54,836 321,363 76,471 661,117
10% 11,537 67,081 32,078 179,260 66,118 368,579 87,676 707,849
Median 22,621 113,215 53,677 247,442 101,286 461,107 125,927 819,752
90% 65,700 175,863 100,764 330,520 155,169 561,098 184,154 936,189
97.5% 98,213 210,156 134,185 379,177 204,127 617,048 229,720 1,014,324
Maximum 172,710 369,426 249,550 498,883 315,804 766,752 299,365 1,100,719
OIF/OEF = Operation Iraqi Freedom/Operation Enduring Freedom, SD = standard deviation.
Table 6.
Cost projections (in U.S. dollars) from Markov model: Unilateral lower-limb groups (n = 178 and 172 for Vietnam and OIF/OEF groups, respectively).
Variable
5 Yr 10 Yr 20 Yr Lifetime
Vietnam OIF/OEF Vietnam OIF/OEF Vietnam OIF/OEF Vietnam OIF/OEF
Mean 82,251 228,665 167,848 473,951 281,234 855,907 342,716 1,463,624
SD 13,781 43,422 20,170 60,221 25,260 80,299 27,633 105,298
Minimum 47,009 111,808 108,111 314,185 212,130 650,945 250,827 1,173,442
2.5% 56,640 159,909 131,142 371,202 234,386 716,922 290,000 1,278,190
10% 65,016 177,646 142,413 400,314 248,761 753,570 307,240 1,330,318
Median 81,594 223,423 166,879 469,346 280,316 849,568 341,948 1,457,508
90% 99,883 287,275 195,407 553,705 313,593 961,003 377,975 1,596,933
97.5% 110,530 320,205 209,563 602,491 331,368 1,019,595 397,515 1,686,589
Maximum 137,645 424,167 233,077 690,358 378,605 1,274,676 466,227 1,841,585
OIF/OEF = Operation Iraqi Freedom/Operation Enduring Freedom, SD = standard deviation.397
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$131,900. Bilateral upper-limb loss and unilateral lower-
limb loss mean lifetime costs are similar at $367,109 and 
$342,716, respectively. Multiple limb  loss is  associated 
with the highest mean lifetim e cost of  $569,674. Over 
longer time spans , costs inc rease  at  a  decreasing rate 
because of deaths within each group.
The mean costs for the 283 members of the OIF/OEF 
group are  several times  higher than the corresponding 
costs for the Vietnam group, as shown in Figure 5. This 
may be a  reflection of higher functional levels and  the 
use of more technologically advanced prostheses, use of 
multiple types of prosthetic  devices, and  a longer pro -
jected length of life from the baseline survey date to the 
end of life. Average lifetime costs for the OIF/OEF group 
with unilateral upper -limb  loss were the lowe st  at 
$823,299. Multiple limb loss has the highest average life-
time costs in the OIF/OEF group at $2,901,365.
A  sensitivity analysi s was employed on  the  two 
cohorts for all modeling  scenarios to asse ss the robust-
ness of  our transition probability specificat ions. The 
results for lifetime  cos ts for the OIF/OEF cohort are  
shown in Table 9 . These results show that the mean pro-
jected costs and the standard deviation of costs are very 
similar to those obtained in  Tables 5  to  8. Results (not 
shown) were similar for the Vietnam cohort and the other 
time horizons for both groups. Thus, our results appear to 
be robust with respect to  the specification of trans ition 
probabilities.
DISCUSSION
We estimated 5-year, 10-year, 20-year, and  lifetime 
prosthetic and assistive device costs for veterans and ser-
vicemembers with major  traumatic limb loss  associated 
with combat-theater injury . We found average projected  
5-year costs for  prosthetic devices and a ssistive devices 
for the OIF/OEF  group were 2.8-fold to 3.8-fold higher 
Table 7.
Cost projections (in U.S. dollars) from Markov model: Bilateral upper-limb groups (n = 6 and 7 for Vietnam and OIF/OEF groups, respectively).
Variable
5 Yr 10 Yr 20 Yr Lifetime
Vietnam OIF/OEF Vietnam OIF/OEF Vietnam OIF/OEF Vietnam OIF/OEF
Mean 90,065 333,445 186,245 674,628 306,513 1,251,827 367,109 2,158,244
SD 24,637 99,704 34,938 134,858 43,824 192,623 45,833 227,935
Minimum 18,192 71,236 87,493 321,705 165,004 673,994 236,006 1,490,563
2.5% 42,116 155,159 122,803 404,725 224,583 880,748 283,022 1,731,502
10% 58,706 208,830 142,946 510,386 251,686 1,011,698 308,896 1,878,160
Median 89,076 326,882 183,548 671,155 304,581 1,245,086 366,398 2,145,882
90% 122,870 468,743 231,972 853,533 362,187 1,497,624 428,499 2,449,681
97.5% 138,383 546,578 261,121 937,910 391,667 1,639,430 460,131 2,626,264
Maximum 159,051 682,594 313,138 1,076,554 434,098 2,110,817 507,181 2,873,933
OIF/OEF = Operation Iraqi Freedom/Operation Enduring Freedom, SD = standard deviation.
Table 8.
Cost projections (in U.S. dollars) from Markov model: Multiple limb groups (n = 67 and 54 for Vietnam and OIF/OEF groups, respectively).
Variable
5 Yr 10 Yr 20 Yr Lifetime
Vietnam OIF/OEF Vietnam OIF/OEF Vietnam OIF/OEF Vietnam OIF/OEF
Mean 130,980 453,696 266,650 933,335 455,051 1,674,333 569,674 2,901,365
SD 25,768 77,714 35,963 107,370 48,820 142,539 58,282 165,399
Minimum 72,095 235,042 173,522 659,750 316,296 1,278,076 414,119 2,378,366
2.5% 90,478 315,345 203,744 734,229 363,986 1,402,603 461,952 2,562,500
10% 100,940 359,353 221,394 801,633 393,937 1,295,707 494,850 2,689,710
Median 127,705 445,541 263,332 926,023 453,086 1,670,658 565,282 2,905,781
90% 165,759 561,315 312,979 1,071,590 514,281 1,853,019 648,537 3,110,067
97.5% 192,432 616,403 342,824 1,154,180 557,298 1,989,918 689,224 3,220,207
Maximum 251,243 767,878 452,730 1,299,842 690,155 2,162,380 750,785 3,488,108
OIF/OEF = Operation Iraqi Freedom/Operation Enduring Freedom, SD = standard deviation.398
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than in  the Vietnam group. Similarly , 10-year, 20-year, 
and lifetime costs ranged from 2.8-fold to 6.2-fold higher 
for the OIF/OEF group. There  are several important rea-
sons for these differences.
Reported  prosthetic a nd a ssistive device  use  is 
greater in the OIF/OEF  group than the V ietnam group. 
For assistive device use, 50 percent of the Vietnam group 
and 57 percent of the OIF/OEF group reported use of a 
wheelchair [14]. Of survey  participants with unilateral 
upper-limb loss, 30 percent of the V ietnam group and 
44 percent of the OIF/OEF group reported current use of 
assistive devices. For unila teral lower-limb loss, 62 per -
cent of the Vietnam group and 69 percent of the OIF/OEF 
group currently use assistive devices to aid mobility [14].
Another reason for cost differences between groups is 
related to the type and  average number of prosthetic and 
assistive devices  used by survey  participants.  Specifi-
cally, greater numbers of technologically advanced 
devices are used  by  the O IF/OEF  group. The current 
annual rate of reported prosthetic device use by limb-loss 
level for th e OIF/OEF group is 1.8-fold hig her/year for 
unilateral upper-limb loss [12], 2.6 -fold higher/year for 
unilateral lower-limb loss [11], and 15.3-fold higher/year 
for multiple limb loss [13] than for the Vietnam group.
Historical reimbursement pra ctices for  prosthetists 
and prosthetic devices have typ ically bundled costs for 
care, professional services, and devices. While most pro-
fessional healthcare  providers  rec eive re imbursement 
based on professional services rendered, Medicare  and 
private practi ce  prosthetists receiv e bu ndled  prosthetic 
reimbursement that covers all ra w materials; purcha sed 
components; prosthetists’ professional evaluation, fabri-
cation, final fittings, and follow-up adjustments; material 
and labor ove rheads; genera l a nd administrative  costs; 
and minimal profit. Medicare reimbursement values for 
prosthetic devices are readily available and accepted and 
therefore were used in this study.
An initial objective for this  study was  to  compare 
three costs scenarios for prosthetic device care: Medicare, 
VA in-house, and private practice. However, variations in 
costs and pricing practices made this impractical. Private- 
practice prosthetics costs are generally assumed to be bill-
ings to  t hird-party  insurers tha t  reflect ba se Medicare  
costs and Medicare nonallowable services. Actual private-
practice costs vary  widely amongst practitioners and are 
not freely published. Certified prosthetists in VA medical 
center prosthetics laborator ies make  approximately 
5 percent of  veterans’ pros thetic  devices from compo -
nents. The VA then contracts with  nationally accredited 
local prosthetic-device businesses to produce the remain-
ing 95 percent o f the device s. These private prosthetic 
providers are reimbursed by the VA at  5 to 10 percent 
Figure 4.
Average projected costs (in U.S. dollars) following limb loss for Viet-
nam group (lifetime is 100 yr).
Figure 5.
Average proj ected  costs ( in  U.S.  dollars)  following li mb loss for 
Operation Iraqi  Freedom/Operation Enduring Freedom group ( life-
time is 100 yr).399
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below Medicare rates.* We anticipated using the VA Deci-
sion Support System (DSS),  a national automated man-
agement information system that integrates clinical and 
financial data  systems for pr osthetics [31],  to perform  a 
VA prosthetics cost  accounting of veteran- specific pros-
thetic utilization and costs. The available DSS prosthetics 
data reviewed at several VA sites were not able to identify 
veteran-specific components and devices;  therefore, this 
portion of the analysis was not pursued.
We compared our cost estimates with those published 
in the literature  to  the exte nt possible,  given that our 
objective was to project future costs while published lit-
erature attempted to summarize current or prior cos ts. A 
study by Williams with a population similar to the Viet-
nam unilateral lower-limb group found costs that com -
pare in order of magnitude to those we obtained for t he 
unilateral lower -limb  groups  [32]. W illiams’s analysis 
lacks a probabilistic framewo rk (necessary measures of 
uncertainty, such as standard errors).  Our review  of the 
literature al so ident ified a  limited  number of studies 
involving limb  loss and projec ted costs of prosthetic 
devices with limited numbers of patient s lacking repre-
sentativeness; thus, these findings cannot be widely gen-
eralized [9,33].
Stewart and Jain performe d a retrospe ctive study of 
98 British veterans from World Wars I and II, the Korean 
war, and the F alklands war who suffered limb loss [33]. 
The study used medical records to determine costs, minus 
those due to residual limb socks, transport, and social 
security payments. The authors indicate that the resulting 
average lifetime cost for th is group in United Kingdom 
pound sterling was  69  million  ($111 million Unit ed 
States dollars [USD]) and  is  likely an  underestimate. 
Measures of uncertainty are not provided, so the general-
izability of these results is limited.
Brodtkorb et al. used Markov models in a small study 
of 20 patients with lower-limb loss to compare the 8-year 
cost of C-leg  prostheses against me chanical prostheses 
[9].  The stud y fo und h igher  8-year costs for  C-legs 
(25,146 Euros [$36,920 USD] vs 17,488 Euros [$25,679 
USD] for mechanical legs). The study did not account for 
multiple prosthetic use, chan ging  functional states, or 
lifetime costs.
Our cost estimates add to  the body of literature and 
show  differences in the number of prosthe tic  devices 
used for the  two conflicts.  The application of Markov 
methods was useful  to estimate lifetime costs of pros -
thetic device use. There were no clear clinical guidelines 
for structuring the model for injured veterans or service -
members with major limb loss. We outlined our assump-
tions in the “Methods” section (p. 388). Lack of previous 
studies and limited published evidence led us to empiri-
cally derived costs and opinion-derived probabilities with 
carefully quantified uncertai nty parameters. The results 
of this study can serve as a n aid for VA decision makers 
in planning for future care of veterans and servicemem-
bers with  major limb loss.  Through the use of Markov 
models, our approach not only provides cost projections  
over a nu mber of time horizons but also includes esti-
mates of uncertainty. The models are based on probabil-
ity  distributions and so  have a firm statistical 
underpinning, given their structure. Our results have face 
validity when compared with other studies and their esti-
mates of cumulative costs.  Thus, our simulation of the 
two groups of Vietnam veterans and OIF/OEF service-
members mo ving thro ugh time an d accruin g co sts 
appears reasonable.
The maximum cost, as indicated  in  the  last row  of 
Tables 5  to 8, is conservative, as it does not include outli-
ers, the cost of future emer ging technologies, or advances 
in surgical procedures. No  model can accurately predict  
outliers (survey participants  with extremely large costs), 
yet such values are typical in medical cost data. Our values 
indicate a reasonable estimate of how large average cumu-
lative cost might be, given the structure of the model. For 
example, for the OIF/OEF unilateral lo wer-limb group, 
Table 9.
Sensitivity analysis: Cost  projections for “worst case” Dirichlet distribution with all parameters set at 0.3. Operation Iraqi Freedom/Operation 
Enduring Freedom lifetime costs (in U.S. dollars).
Projected Cost Unilateral Lower Limb Unilateral Upper Limb Bilateral Upper Limb Other Multiple Limb
Mean ± SD 1,311,571 ± 150,105 877,039 ± 103,442 1,922,782 ± 227,874 2,657,459 ± 256,326
SD = standard deviation.
*Eckrich, Neal. (Natio nal Program Director, Prosthetic and Sensor y 
Aids Service, VA Central Of fice, Washington, DC). Perso nal com-
munication to: Gayle E. Reiber  (Program Analyst, Department  of 
Prosthetic and Sensory Aids, VA Puget Sound Health Care System, 
Seattle, WA). 2009 Mar 16.400
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even though the expected lifetime costs are approximately 
$1.4 million, the range reaches a high of $1.8 million.
Research has defined the impact of combat on mental 
health, physical health, and mortality [34]. Future research 
is needed to model comorbidities of veterans and service-
members, including specifi c  physical  and mental health 
conditions. The death rates we  used are based on popula-
tion averages and do not account for specific chronic dis-
eases such as diabetes and posttraumatic stress disorder.
Finally, the Markov model developed in this article is 
based on functional  status with  the goal of  cost projec-
tion. Formal cost-effectiveness analysis was not the pur-
pose of this article. Future studies could focus on both 
cost and effectiveness.
CONCLUSIONS
Based on our findings of modest cost increases when 
projecting prosthetic device use for th e next 5, 10, and 
20 years and lifetime for the number of veterans and ser-
vicemembers from Vietnam and OIF/OEF with traumatic 
limb loss, future prosthetic healthcare costs may be man-
ageable for the VA and DOD  facilities, providing avail-
able resources do not change dramatically. The lifetime 
cost projections do not account for significant changes in 
health policies or practices. Our study found higher costs 
associated with the OIF/OEF servicemembers, especially 
those with multiple limb loss, given the higher number of 
devices used and newer advanced technologies. The VA 
and other healthcare provider systems should be prepared 
for the increase in  more advanced technologies a nd use 
of multiple prosthetic devices. This preparation for these 
advanced devices may  include training for prosthetists 
and res ources to  support their use  and maintena nce. 
Future  technologies suc h as the Defense   Advanced 
Research Projects Agency (DAR PA) arm [35–36] may 
dramatically increase future  costs. Healthcare providers 
and policy makers will benefit from an understanding of 
current cost projections and a uniform approach for cov-
erage of prosthetic and assistive devices for all veterans 
and servicemembers with major traumatic limb loss.
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